search
Back to results

Eustachian Tube Dilation With an Endovascular Balloon

Primary Purpose

Eustachian Tube Dysfunction, Eustachian Tube Dysfunction of Both Ears

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Eustachian tube dilation
Sponsored by
Sunnybrook Health Sciences Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Eustachian Tube Dysfunction

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • ≥18 years old (of both sexes)
  • Diagnosed with unilateral or bilateral persistent obstructive eustachian tube dysfunction (OETD)
  • Undergoing tympanoplasty or tympanomastoidectomy

Exclusion Criteria:

  • Patulous eustachian tube
  • Preoperative nasal endoscopy with evidence of anatomic conditions that would prevent transnasal access to the Eustachian tube
  • CT temporal bone scan with evidence of carotid artery dehiscence, superior semicircular canal dehiscence, or extrinsic eustachian tube compression
  • Patient unable to follow protocol for any reason
  • Cleft palate or Craniofacial syndrome
  • Prior eustachian tube intervention
  • Prior radiation to the head and neck

Sites / Locations

  • Sunnybrook Health Sciences Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Eustachian tube dilation

Arm Description

Eustachian tube dilation with an endovascular balloon

Outcomes

Primary Outcome Measures

Succesfull procedure
o Feasibility to perform the procedure after ear surgery with no local complication and within 15-20 minutes

Secondary Outcome Measures

CT
o Safety evaluated after the procedure CT scan. Complications (adverse and serious adverse events related to the device or procedure)
ETDQ - 7 (Eustachian Tube Dysfunction Questionnaire - Item 7)
o Mean change in overall ETDQ-7 scores from baseline at 2- and 6-months follow-up
Endoscopic evaluation
Safety evaluated after the procedure by endoscopic examination and CT scan. Complications (adverse and serious adverse events related to the device or procedure)

Full Information

First Posted
February 24, 2021
Last Updated
October 25, 2022
Sponsor
Sunnybrook Health Sciences Centre
search

1. Study Identification

Unique Protocol Identification Number
NCT04809753
Brief Title
Eustachian Tube Dilation With an Endovascular Balloon
Official Title
Eustachian Tube Dilation Using an Angioplasty Balloon - a Pilot Safety Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
March 29, 2021 (Actual)
Primary Completion Date
August 20, 2021 (Actual)
Study Completion Date
February 28, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Sunnybrook Health Sciences Centre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The Eustachian tube is a narrow tube which links the back of the nose to the middle ear. Eustachian tube dysfunction may occur when the mucosal lining of the tube is swollen, or does not open or close properly. It can occur after the start of a cold and other nose, sinus, ear and throat infections causing ear pain and pressure, fullness, cracking/popping sounds. This is an ubiquitous healthcare problem, affecting children and adults, that can lead to severe consequences including hearing loss, chronic otitis media, tinnitus, and vertigo. Numerous studies have consistently failed to support the effectiveness of medical managements. Pressure equalizing tubes are considered a temporary solution that does not treat the underlying pathology. More recent preliminary evidence of using inflation of a noncompressible balloon in the eustachian tube improved clinical outcomes, patients' symptoms and quality of life. This eustachian dilation catheter is not accessible in Canada since the device and procedure is not covered by OHIP (Ontario health insurance plan) or any other health insurance in Canada. In a cadaver study, we have evaluated using an endovascular balloon (Balloon that is used to dilate (expand) vessels) for eustachian tube dilation, which only costs about 10% of the eustachian tube dilation device. This endovascular balloon is Health Canada approved, but not for this specific use. We therefore want to conduct a pilot safety study with the main goal of assessing feasibility of eustachian tube dilation with the endovascular device.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Eustachian Tube Dysfunction, Eustachian Tube Dysfunction of Both Ears

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
12 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Eustachian tube dilation
Arm Type
Experimental
Arm Description
Eustachian tube dilation with an endovascular balloon
Intervention Type
Device
Intervention Name(s)
Eustachian tube dilation
Intervention Description
Dilation of the eustachian tube with an endovascular balloon
Primary Outcome Measure Information:
Title
Succesfull procedure
Description
o Feasibility to perform the procedure after ear surgery with no local complication and within 15-20 minutes
Time Frame
20 minutes
Secondary Outcome Measure Information:
Title
CT
Description
o Safety evaluated after the procedure CT scan. Complications (adverse and serious adverse events related to the device or procedure)
Time Frame
5 minutes
Title
ETDQ - 7 (Eustachian Tube Dysfunction Questionnaire - Item 7)
Description
o Mean change in overall ETDQ-7 scores from baseline at 2- and 6-months follow-up
Time Frame
2 minutes
Title
Endoscopic evaluation
Description
Safety evaluated after the procedure by endoscopic examination and CT scan. Complications (adverse and serious adverse events related to the device or procedure)
Time Frame
5 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ≥18 years old (of both sexes) Diagnosed with unilateral or bilateral persistent obstructive eustachian tube dysfunction (OETD) Undergoing tympanoplasty or tympanomastoidectomy Exclusion Criteria: Patulous eustachian tube Preoperative nasal endoscopy with evidence of anatomic conditions that would prevent transnasal access to the Eustachian tube CT temporal bone scan with evidence of carotid artery dehiscence, superior semicircular canal dehiscence, or extrinsic eustachian tube compression Patient unable to follow protocol for any reason Cleft palate or Craniofacial syndrome Prior eustachian tube intervention Prior radiation to the head and neck
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Trung Le, MD
Organizational Affiliation
Sunnybrook Health Sciences Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sunnybrook Health Sciences Center
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4N 3M5
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Individual participant data (consent form (anonymized), study protocol) will be shared upon reasonable request after publication

Learn more about this trial

Eustachian Tube Dilation With an Endovascular Balloon

We'll reach out to this number within 24 hrs